Welcome to Zypher Lifesciences

ZypherLifesciences is the vertically integrated, one of the leading and fastest growing pharmaceutical and life sciences group of companies with its presence in various therapies like Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

History of Zypher Lifesciences Founded in 2008 with a small setup of sales and marketing company to provide quality healthcare products, now we are grown into a company comply with EUGMP manufacturing unit with joint ventures in Europe, Middle East & Japan

Our Milestones

2008

Inception Launch of Domestic Divisions

2010

LVP
Unit

2012

Oncology & Hormone Blocks

2014

R&D
Opening

2016

Addition of General Sections, Suppositories

2018

Expanding footsteps in Exports

2019

Launch of First Patented Product

2020

Upcoming API Sections

Our Products

Zypher Nutraceuticals range is the outcome of excellent precision of Compounding Pharmacy where we use the unique model of Compounding Pharmacy which provides bio-identical, natural extract, high-bioavailability, freshly-compounded & customized products that are mostly plant based.

Oncology

Effervescent

Hormones

Anti-Viral

Download Product List

Our widest range of products gives freedom to our clients to pick the products as per their market demand and epidemiological structure. Currently, we have over 1000 products in key therapeutic segments including hospital based therapeutic segments.

Quality

Zypher is another name of Quality!!!

Our concept is based on Quality by Design (QbD) as we believe that quality cannot be tested into products i.e., quality should be built in by design. QbD is the best solution to build quality in our pharmaceutical products.

We practice Quality by Design (QbD) in such a way that our each product meets the parameter of performance profile [Target product Profile (TPP), Target Product Quality Profile (TPQP)] and it also identifies critical quality attributes (CQA). On the basis of our QbD we can deliver the product formulation and process to meet the product attributes. Our philosophy of QbD leads to recognizing the impact of raw materials [critical material attributes (CMA), critical process parameters (CPP) on the CQAs and identification and control sources of variability. Our quality system offers the pharmaceutical product with increased self-regulated flexibility while maintaining tight quality standards and real time release of the drug product.

Our each action is taken to deliver products with exceptional quality to address the needs of patients. We maintain complete transparency in every aspect of our production till final dispatch of goods, which ultimately results in utmost quality of pharmaceutical products. Quality par excellence is our only Motto.

Our highly qualified Quality Management Team ensures that each of our every product qualifies global standards of purity, efficacy and safety. Our Quality Assurance and Quality Control is guided by a Corporate Quality Assurance (CQA). CQA ensures the implementation of latest updated ICH guidelines from time to time as per to maintain Good Manufacturing Practices (GMP) and Standard Operating Procedures (SOPs). Our manufacturing sites are regularly audited by CQA & outside authorities to ensure 24x7 compliance and conformance. In addition, our quality management team is also involved in overseeing compliance with respect to Good Clinical Practices (GCP) and Good Laboratory Practices (GLP).

Our Global Presence

Our market presence is widely spread across the globe including Regulated Markets and Emerging Markets.

Our major focus in Regulated Markets as well Semi Regulated Markets, where we have robust sales & distribution network. Our long-term growth and increased profitability in operations will continue with the year after year increasing contribution from these Regulated Markets.

The presence in Emerging Markets includes the regions of Asia, Africa, CIS, MENA (Middle East & North Africa), Russia, and Latin America, where the marketing strategy is to enhance company's visibility at a global forefront and connect with customers & business associates.